*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Punya Mardhanan - CMaT event inquiries
Summary Sentence: Real-Time Optical Sensors for Cell Culture
Full Summary: No summary paragraph submitted.
CMatPARTICIPATION LINK
In this Lunch and Learn presentation, we share how we have combined multiple sensors in suitable form factors for the measurement of pH and dissolved oxygen in a range of culture systems such as multi-well culture plates, microfluidics devices, shake flasks, and bioreactors.
Scientific Bioprocessing Inc. Presenters:
Personalized medicine in cell and gene therapy has moved therapeutics development back to small scale bioreactors and added new process constraints: cost and form factor. SBI has developed technologies that overcome these challenges and allow researchers to collect real-time sensing data with non-invasive, biocompatible, sterilizable sensors.
We will also present our new fiber optic sensor platform that allows for sensing measurements inside a bioreactor at multiple locatins in a perfusion flow loop upstream or downstream of the bioreactor. This mapping can reveal stagnation zones, insufficient mixing and other process improvement opportunities.
While overcoming form factor limitations is highly beneficial for personalized medicine applications, multi-sensing platforms are also critical in bioprocessing and in increasing reproducibility, reducing cost, and resulting in better cell outcomes. We welcome the CMaT community to this presentation and offer evaluations of our technology to the CMaT researchers to encourage collaborations and help accelerate the development and commercialization of cell therapies.
